Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.54 |
| ▸ | NQO2 | P16083 | 4/20 | 0.49 |
| ▸ | NQO1 | P15559 | 1/20 | 0.47 |
| ▸ | RELA | Q04206 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.47 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | TUBB4A | P04350 | 2/20 | 0.43 |
| ▸ | TUBB | P07437 | 2/20 | 0.43 |
| ▸ | TUBA3C | P0DPH7 | 2/20 | 0.43 |
| ▸ | TUBA1B | P68363 | 2/20 | 0.43 |
| ▸ | TUBA4A | P68366 | 2/20 | 0.43 |
| ▸ | TUBB4B | P68371 | 2/20 | 0.43 |
| ▸ | TUBB3 | Q13509 | 2/20 | 0.43 |
| ▸ | TUBB2A | Q13885 | 2/20 | 0.43 |
| ▸ | TUBB8 | Q3ZCM7 | 2/20 | 0.43 |
| ▸ | TUBA3E | Q6PEY2 | 2/20 | 0.43 |
| ▸ | TUBA1A | Q71U36 | 2/20 | 0.43 |
| ▸ | TUBA1C | Q9BQE3 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL442275 | 0.85 | KDM4E (0.57) | FDPSNQO2RELACYP1A2KDM4E | |
| SCHEMBL442274 | 0.85 | KDM4E (0.57) | FDPSNQO2RELACYP1A2KDM4E | |
| SCHEMBL2719499 | 0.84 | NQO1 (0.49) | NQO2NQO1RELACYP1A2CYP2A6 | |
| SCHEMBL8928081 | 0.82 | RELA (0.61) | FDPSNQO2RELACYP1A2TUBB4A | |
| SCHEMBL8928082 | 0.82 | RELA (0.61) | FDPSNQO2RELACYP1A2TUBB4A | |
| SCHEMBL1520052 | 0.79 | RELA (0.59) | FDPSNQO2RELAKDM4ECYP3A4 | |
| SCHEMBL1520048 | 0.79 | RELA (0.59) | FDPSNQO2RELAKDM4ECYP3A4 | |
| Acrylonitrile SCHEMBL3692654 | 0.79 | KDM4E (0.50) | FDPSNQO2RELACYP1A2KDM4E | |
| Acrylonitrile SCHEMBL3692651 | 0.79 | KDM4E (0.50) | FDPSNQO2RELACYP1A2KDM4E | |
| SCHEMBL9494220 | 0.77 | LMNA (0.69) | NQO2RELACYP1A2CYP2A6KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3625218-B1 | PROCESS FOR HYDROCYANATION OF TERMINAL ALKYNES | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2023-03-01 | — | — | EP | disclosed |
| EP-3625218-B1 | PROCESS FOR HYDROCYANATION OF TERMINAL ALKYNES | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2023-03-01 | — | — | EP | disclosed |
| US-10947186-B2 | Process for hydrocyanation of terminal alkynes | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2021-03-16 | — | — | US | disclosed |
| US-10947186-B2 | Process for hydrocyanation of terminal alkynes | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2021-03-16 | — | — | US | disclosed |
| US-20200181068-A1 | PROCESS FOR HYDROCYANATION OF TERMINAL ALKYNES | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2020-06-11 | — | — | US | disclosed |
| US-20200181068-A1 | PROCESS FOR HYDROCYANATION OF TERMINAL ALKYNES | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2020-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200181068-A1 | PROCESS FOR HYDROCYANATION OF TERMINAL ALKYNES | ALKBH3, ALKBH2, ALKBH5 | FDPS 3081/4885NQO2 902/4885NQO1 1553/4885 |
| US-10947186-B2 | Process for hydrocyanation of terminal alkynes | ALKBH3, ALKBH2, ALKBH5 | FDPS 3081/4885NQO2 902/4885NQO1 1553/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.